22 October 2002: The Federal Ministry for Food chain safety and Environment gives a final decision (positive) for this trial.
Trial reference:
Phase II study evaluating the clinical efficacy of TG4010 (MVA-MUC1-IL2) in patients with metastatic Renal Cell Carcinoma (RCC)